OWP
TMO icon

Obermeyer Wealth Partners’s Thermo Fisher Scientific TMO Stock Holding History

Obermeyer Wealth Partners’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$342K Sell
695
-23
-3% -$12.5K 0.02% 220
2025
Q4 		$416K Sell
718
-411
-36% -$232K 0.02% 194
2025
Q3 		$548K Sell
1,129
-12
-1% -$5.59K 0.03% 155
2025
Q2 		$463K Sell
1,141
-10
-0.9% -$4.18K 0.02% 168
2025
Q1 		$573K Sell
1,151
-49
-4% -$26.5K 0.03% 137
2024
Q4 		$624K Sell
1,200
-152
-11% -$83.6K 0.03% 127
2024
Q3 		$836K Hold
1,352
– – 0.04% 113
2024
Q2 		$748K Buy
1,352
+45
+3% +$25.8K 0.04% 115
2024
Q1 		$760K Buy
1,307
+199
+18% +$112K 0.04% 108
2023
Q4 		$588K Sell
1,108
-479
-30% -$232K 0.04% 101
2023
Q3 		$803K Hold
1,587
– – 0.06% 79
2023
Q2 		$828K Buy
1,587
+488
+44% +$263K 0.06% 82
2023
Q1 		$633K Sell
1,099
-86
-7% -$48.5K 0.05% 100
2022
Q4 		$653K Sell
1,185
-191
-14% -$101K 0.05% 93
2022
Q3 		$698K Hold
1,376
– – 0.06% 79
2022
Q2 		$748K Buy
1,376
+17
+1% +$9.36K 0.05% 80
2022
Q1 		$803K Buy
1,359
+1,000
+279% +$574K 0.05% 92
2021
Q4 		$240K Hold
359
– – 0.01% 201
2021
Q3 		$205K Buy
+359
New +$197K 0.01% 206

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Obermeyer Wealth Partners's TMO Position: Q1 2026 in Review

Obermeyer Wealth Partners reduced its Thermo Fisher Scientific (TMO) stake by 3.2% in Q1 2026, selling an estimated $12.5K and leaving 695 shares worth $342K. The position accounts for 0.02% of the portfolio, ranked #220.

Obermeyer Wealth Partners first reported a position in TMO in Q3 2021 and has held it in 19 quarters since. The position peaked at $836K in Q3 2024. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Obermeyer Wealth Partners held 695 shares of Thermo Fisher Scientific worth $342K as of Q1 2026.
  • Obermeyer Wealth Partners sold 23 Thermo Fisher Scientific shares in Q1 2026, an estimated $12.5K.
  • Thermo Fisher Scientific made up 0.02% of Obermeyer Wealth Partners's portfolio in Q1 2026, its #220 holding.
  • Obermeyer Wealth Partners first reported a position in Thermo Fisher Scientific in Q3 2021 and has held it in 19 quarters since.
  • Obermeyer Wealth Partners's Thermo Fisher Scientific position peaked at $836K in Q3 2024.
  • 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Obermeyer Wealth Partners's 13F filing for Q1 2026, filed 21 Apr 2026.